Fast-Track Health and VitaLync today announced the signing of a Memorandum of Understanding (MOU) establishing a strategic partnership to expand global access to innovative regenerative wound care technologies for people living with diabetes and other chronic ulcerative and wound-related conditions.
The partnership combines VitaLync's expertise in regenerative medicine and advanced wound care with Fast-Track Health's global implementation science capabilities, municipal partnerships, and experience supporting the translation of innovation into sustainable improvements in healthcare delivery. Under the MOU, the Fast-Track Cities Institute will serve as a supporting partner by providing technical assistance, implementation expertise, educational resources, and engagement with participating Fast-Track Cities.
“Our collaboration with VitaLync reflects Fast-Track Health's commitment to accelerating the adoption of evidence-based innovations that improve both clinical outcomes and health equity. Too many people living with diabetes experience preventable complications from chronic wounds that profoundly affect quality of life, healthcare costs, and survival. By combining provider education and municipal partnerships with VitaLync's innovative regenerative technology, we have an opportunity to help health systems deliver more effective, person-centered wound care.”
Dr. José M. Zuniga President / CEO, Fast-Track Health
“At VitaLync, our mission is to expand access to allograft technologies while ensuring that patients and clinicians have access to the education and support needed to use them effectively. We are excited to partner with Fast-Track Health because of its relationships with cities, healthcare systems, and public health leaders around the world. Together, we can demonstrate how innovation can improve care for people living with chronic wounds and create scalable models that benefit communities globally.”
Valerie Cruz Founder & Chief Executive Officer, VitaLync
The MOU outlines several areas of collaboration, including strengthening clinical education and provider capacity, expanding equitable access to advanced wound care, generating real-world evidence through implementation science, and developing best-practice care models. The organizations will also collaborate on scientific publications, case studies, policy briefs, conference presentations, and educational initiatives to disseminate lessons learned and promote evidence-based adoption of advanced wound care technologies.
About Fast-Track Health
Fast-Track Health is a global health organization dedicated to accelerating responses to communicable and non-communicable diseases and addressing the health impacts of climate change. Through data-driven accountability, workforce development, policy innovation, and integrated urban-national collaboration, Fast-Track Health works to achieve the health-related Sustainable Development Goals and build resilient, equitable health systems worldwide.
About VitaLync
VitaLync is an FDA-registered tissue bank advancing regenerative medicine through cutting-edge allograft technologies designed to improve healing outcomes for people living with chronic wounds and other complex conditions. Through scientific innovation, clinical education, and strategic partnerships, VitaLync expands access to regenerative therapies and supports scalable, person-centered care models that improve patient quality of life and health equity.